HUMAN ANAPLASMOSIS

This adverse event was reported 83 times

HUMAN ANAPLASMOSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ADALIMUMAB-RYVK 1 0.0009
1 BARICITINIB 2 0.0007
2 DOXYCYCLINE MONOHYDRATE 1 0.0006
3 EMPAGLIFLOZIN AND LINAGLIPTIN 1 0.0005
4 MERCAPTOPURINE 5 0.0003
5 ERGOCALCIFEROL 6 0.0002
6 GLYCOPYRROLATE 1 0.0002
7 CARBOXYMETHYLCELLULOSE SODIUM 1 0.0002
8 SODIUM BICARBONATE INJECTION, 4 0.0002
9 UBROGEPANT 1 0.0002
See all drugs enriched for association with HUMAN ANAPLASMOSIS